Jacky Vonderscher
Lyon, 69008, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 22, 2024
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.
Journal: Journal of hepatology
Published: August 22, 2022
Combining robust urine biomarkers to assess chronic kidney disease progression.
Journal: EBioMedicine
Published: July 14, 2022
An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters.
Journal: Communications biology
Published: September 26, 2021
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study.
Journal: Journal of viral hepatitis
Published: July 07, 2021
Chemical targeting of NEET proteins reveals their function in mitochondrial morphodynamics.
Journal: EMBO reports
Published: August 07, 2019
Virus-host interactomics: new insights and opportunities for antiviral drug discovery.
Journal: Genome medicine
Published: January 17, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026